Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.

Monitoring response to therapeutic interventions in patients with cancer.

Herrmann K, Krause BJ, Bundschuh RA, Dechow T, Schwaiger M.

Semin Nucl Med. 2009 May;39(3):210-32. doi: 10.1053/j.semnuclmed.2008.12.001. Review.

PMID:
19341841
2.

Monitoring cancer treatment with PET/CT: does it make a difference?

Weber WA, Figlin R.

J Nucl Med. 2007 Jan;48 Suppl 1:36S-44S. Review.

3.

Use of PET for monitoring cancer therapy and for predicting outcome.

Weber WA.

J Nucl Med. 2005 Jun;46(6):983-95. Review.

4.

Response to therapy in breast cancer.

Avril N, Sassen S, Roylance R.

J Nucl Med. 2009 May;50 Suppl 1:55S-63S. doi: 10.2967/jnumed.108.057240. Epub 2009 Apr 20. Review.

6.

Monitoring response to treatment in patients utilizing PET.

Avril NE, Weber WA.

Radiol Clin North Am. 2005 Jan;43(1):189-204. Review.

PMID:
15693656
7.

18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.

Krause BJ, Herrmann K, Wieder H, zum Büschenfelde CM.

J Nucl Med. 2009 May;50 Suppl 1:89S-96S. doi: 10.2967/jnumed.108.057232. Epub 2009 Apr 20. Review.

8.

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.

9.

Assessing tumor response to therapy.

Weber WA.

J Nucl Med. 2009 May;50 Suppl 1:1S-10S. doi: 10.2967/jnumed.108.057174. Epub 2009 Apr 20. Review.

10.

PET monitoring of therapy response in head and neck squamous cell carcinoma.

Schöder H, Fury M, Lee N, Kraus D.

J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. Review.

11.

The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.

Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D.

J Nucl Med. 2009 May;50 Suppl 1:64S-73S. doi: 10.2967/jnumed.108.057257. Epub 2009 Apr 20. Review.

12.

Relevance of positron emission tomography (PET) in oncology.

Weber WA, Avril N, Schwaiger M.

Strahlenther Onkol. 1999 Aug;175(8):356-73. Review.

PMID:
10481766
13.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
14.

Clinical applications of positron emission tomography-computed tomography in oncology.

Kumar R, Halanaik D, Malhotra A.

Indian J Cancer. 2010 Apr-Jun;47(2):100-19. doi: 10.4103/0019-509X.62997. Review.

15.

FDG-PET/CT for cancer management.

Otsuka H, Morita N, Yamashita K, Nishitani H.

J Med Invest. 2007 Aug;54(3-4):195-9. Review.

16.

Established, emerging and future applications of FDG-PET/CT in the uterine cancer.

Kitajima K, Murakami K, Kaji Y, Sakamoto S, Sugimura K.

Clin Radiol. 2011 Apr;66(4):297-307. doi: 10.1016/j.crad.2010.07.012. Epub 2011 Jan 14. Review.

PMID:
21356392
17.

FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.

Kuo PH, Carlson KR, Christensen I, Girardi M, Heald PW.

Mol Imaging Biol. 2008 Nov-Dec;10(6):306-14. doi: 10.1007/s11307-008-0161-4. Epub 2008 Jul 30.

PMID:
18665425
18.

18F-FDG PET and PET/CT in the evaluation of cancer treatment response.

Ben-Haim S, Ell P.

J Nucl Med. 2009 Jan;50(1):88-99. doi: 10.2967/jnumed.108.054205. Review.

19.

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.

Czernin J, Benz MR, Allen-Auerbach MS.

Eur J Radiol. 2010 Mar;73(3):470-80. doi: 10.1016/j.ejrad.2009.12.023. Epub 2010 Jan 25. Review.

PMID:
20097498
20.

Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.

de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graaf WT, Oyen WJ.

J Nucl Med. 2009 May;50 Suppl 1:43S-54S. doi: 10.2967/jnumed.108.057224. Review.

Items per page

Supplemental Content

Write to the Help Desk